HomeFUNDING

FUNDING

Perspectum Closes $36M Financing Round

Perspectum funding will drive the commercialization of LiverMultiScan® for clinical use, expand the CRO business as well as develop additional products for biliary disease, diabetes and cancer for both clinical and CRO applications.

54gene Closes $15M Series A

54gene notes the round included participation from Raba Capital, V8 Capital, Ingressive Capital, and follow on investment from Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC and Pioneer Fund.

Halo Labs Closed a $12M Series B1 Financing Round led by Research Corporation Technologies

In addition, Halo Labs is actively looking at acquiring complementary technologies and companies to expand into the analytical particle space.

ShiraTronics, Inc. Completes $3 Million Additional Series A Financing

Financing was provided by Breakout Ventures (BOV). BOV joins previous Series A lead investors USVP, Amzak Health, and Strategic HealthCare Investment Partners (S.H.I.P), with participation from Aperture Ventures, LivaNova PLC, and a leading Academic Institution.

RubiconMD Secures $18M in Series C Financing Led by Deerfield Management Company

To date, RubiconMD has raised more than $40 million.

Zeto Raises Series A Funding

Zeto raised $4 million previously in dilutive and non-dilutive funding. The new capital will be used to accelerate the commercialization of its lead product.

Coronavirus News: Mologic Awarded c.£1 Million by UK Government to Develop Rapid Diagnostic Test

Mologic reports funding will be used by Mologic and global partners, to develop a point-of-need diagnostic test for the virus, in addition to supporting the Company to initiate research for novel vaccine candidates.

Supira Medical, A Shifamed Portfolio Company, Closes $35M In Series B Financing

Additionally, Supira Medical announced the appointment of seasoned medical device executive, Dr. Nitin Salunke, as President and Chief Executive Officer.

Carevive Systems Raises New Financing Round with Philips and Debiopharm

Company reports the new funding round will strengthen position as the market leader in understanding and improving the cancer patient experience.